Get the Stockscreener App
0.923
1.26%
0.0115
Intercure Ltd stock is traded at $0.923, with a volume of 39,762.
It is up +1.26% in the last 24 hours and down -7.05% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
See More
Previous Close:
$0.9115
Open:
$0.926
24h Volume:
39,762
Relative Volume:
0.53
Market Cap:
$50.47M
Revenue:
$118.18M
Net Income/Loss:
$5.99M
P/E Ratio:
6.9977
EPS:
0.1319
Net Cash Flow:
$-12.91M
1W Performance:
-0.97%
1M Performance:
-7.05%
6M Performance:
-36.78%
1Y Performance:
-44.73%
1-Day Range:
$0.9201
$0.94
1-Week Range:
$0.9002
$0.9699
52-Week Range:
$0.68
$1.7799
Intercure Ltd Stock (INCR) Company Profile
Compare INCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.923 | 49.84M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
124.82 | 53.64B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.23 | 54.24B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
HLN
Haleon Plc Adr
|
10.47 | 45.87B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.08 | 37.94B | 17.39B | 1.43B | 774.28M | 1.219 |
|
UTHR
United Therapeutics Corp
|
469.49 | 20.14B | 3.13B | 1.27B | 1.12B | 26.39 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
Head-To-Head Contrast: InterCure (NASDAQ:INCR) versus CompuMed (OTCMKTS:CMPD) - Defense World
Quarterly Trades: Is InterCure Ltd exposed to currency risks2025 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Does InterCure Ltd. stock benefit from AI growthWeekly Profit Report & Risk Controlled Daily Trade Plans - mfd.ru
RSI Check: Is InterCure Ltd undervalued by DCF analysisMarket Movers & Low Risk Entry Point Tips - baoquankhu1.vn
Surprises Report: Is InterCure Ltd a potential multi baggerWeekly Loss Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Why Investors Shouldn't Be Surprised By InterCure Ltd.'s (TLV:INCR) 29% Share Price Plunge - simplywall.st
Will InterCure Ltd. stock gain from strong economyEarnings Recap Summary & Community Trade Idea Sharing Platform - Улправда
Published on: 2026-01-12 07:36:04 - ulpravda.ru
Can InterCure Ltd. stock attract ESG capital inflows2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Улправда
Will InterCure Ltd. stock attract ESG investorsJuly 2025 Gainers & Smart Swing Trading Alerts - Улправда
Top Cannabis Stocks To Watch Today – January 1st - Defense World
Wall Street Recap: How InterCure Ltd stock compares to market leadersJuly 2025 Technicals & Stepwise Swing Trade Plans - moha.gov.vn
InterCure (NASDAQ:INCR) Shares Down 6.6% – Should You Sell? - Defense World
InterCure Shareholders Approve All Proposals at 2025 Annual Meeting - TipRanks
We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed - simplywall.st
Why InterCure Ltd. stock could see breakout soonInterest Rate Changes & Zero-Cost Stock Research by Professionals - bollywoodhelpline.com
Critical Contrast: InterCure (NASDAQ:INCR) & Varex Imaging (NASDAQ:VREX) - Defense World
Is InterCure Ltd. stock a buy for dividend growthJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
How InterCure Ltd. stock compares to market leaders2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Will InterCure Ltd. stock gain from lower inflationDollar Strength & Weekly Market Pulse Updates - DonanımHaber
What valuation multiples suggest for InterCure Ltd. stockEarnings Growth Report & Technical Confirmation Alerts - ulpravda.ru
InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court - marketscreener.com
InterCure Ltd On Dec 15, Became Aware That Bazelet Group Of Companies Has Initiated Restructuring Proceedings Before The Israeli District Court - TradingView — Track All Markets
InterCure Faces NIS 27 Million Exposure as Key Cannabis Partner Bazelet Enters Restructuring - TipRanks
[6-K] Intercure Ltd. Current Report (Foreign Issuer) | INCR SEC FilingForm 6-K - Stock Titan
InterCure (TLV:INCR) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR) - TradingView — Track All Markets
Head to Head Comparison: InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF) - Defense World
How interest rate cuts could boost InterCure Ltd. stockJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
How resilient is InterCure Ltd. stock in market downturnsGold Moves & Expert Approved Trade Ideas - Newser
Is InterCure Ltd. stock a buy before product launchesJuly 2025 Decliners & Weekly Top Performers Watchlists - Newser
Will InterCure Ltd. stock see PE expansionGold Moves & Low Drawdown Trading Strategies - Newser
Why InterCure Ltd. stock appeals to dividend seekersTrade Exit Summary & Verified Entry Point Signals - Newser
US Market Wrap: Can InterCure Ltd. stock deliver sustainable ROEJuly 2025 Intraday Action & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv - Investing.com Nigeria
InterCure Ltd. Schedules Annual General Meeting for December 2025 - TipRanks
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv By Investing.com - Investing.com South Africa
InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy? - Defense World
How InterCure Ltd. stock performs during Fed tightening cyclesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.13%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):